SCHEDULE: CVI Investments & Heights Capital Report 6.9% Strata Skin Stake
Beneficial Ownership Report
CVI Investments, managed by Heights Capital Management, Inc., has disclosed a 6.9% passive beneficial ownership stake in Strata Skin Sciences, Inc.
Summary
- CVI Investments, Inc. and Heights Capital Management, Inc. (as its investment manager) jointly reported beneficial ownership of 365,849 shares of Strata Skin Sciences, Inc. common stock.
- This ownership represents 6.9% of Strata Skin Sciences, Inc.'s total outstanding common stock.
- The filing was made pursuant to Rule 13d-1(c), signifying a passive investment without intent to influence or change control of the issuer.
- Strata Skin Sciences, Inc. had 5,268,708 shares outstanding as of the completion of an offering referenced in a Prospectus Supplement filed on September 3, 2025.
- Heights Capital Management, Inc. exercises shared voting and dispositive power over the shares held by CVI Investments, Inc. through a Limited Power of Attorney dated July 16, 2015.
Sentiment
Score: 5
Explanation: The filing is a routine disclosure of a passive beneficial ownership stake, providing factual information without inherently positive or negative implications for the company's operational performance.
Positives
- A significant institutional investor, CVI Investments, Inc., holds a 6.9% stake in Strata Skin Sciences, Inc., which could be interpreted as a vote of confidence in the company's long-term prospects.
- The investment is explicitly passive, indicating no immediate intent to disrupt management or strategic direction.
Negatives
- No explicit negatives are disclosed in this beneficial ownership report.
Risks
- No specific risks related to Strata Skin Sciences, Inc.'s operations or financial health are detailed in this beneficial ownership filing.
Future Outlook
This filing does not contain any forward-looking statements or guidance from Strata Skin Sciences, Inc. or the reporting persons regarding the issuer's future performance or strategic direction.
Industry Context
This Schedule 13G filing primarily concerns an institutional investment firm's stake in Strata Skin Sciences, Inc. and does not provide specific details on broader industry trends or the competitive landscape. It indicates a significant, passive investment by CVI Investments, Inc. in the dermatology or skin sciences sector.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional stake by CVI Investments, Inc. and Heights Capital Management, Inc. provides transparency regarding the company's ownership structure.
- Management: The passive nature of the investment suggests no immediate direct impact on the company's management or strategic decision-making.
Next Steps
- No specific future actions, events, or milestones for Strata Skin Sciences, Inc. are mentioned in this beneficial ownership filing.
Key Dates
| Date | Description |
|---|---|
| July 16, 2015 | Limited Power of Attorney granted by CVI Investments, Inc. to Heights Capital Management, Inc. |
| December 18, 2024 | Date of the Prospectus (Registration No. 333-283418) to which a supplement was later filed. |
| September 2, 2025 | Date of the event that required the filing of this Schedule 13G statement. |
| September 3, 2025 | Prospectus Supplement (to Prospectus dated December 18, 2024) filed, indicating 5,268,708 shares outstanding as of the completion of the offering referred therein. |
| September 8, 2025 | Date of signing and filing of the Schedule 13G statement. |
Keywords
Strata Skin Sciences, CVI Investments, Heights Capital Management, Beneficial Ownership, SEC Filing, Schedule 13G, Common Stock, Passive Investment, Institutional Investor, Dermatology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.